T1	disease 102 129	papillary thyroid carcinoma
T2	gene 161 166	SFRP1
T3	gene 249 259	ST6GALNAC1
T4	disease 349 354	tumor
T5	gene 419 423	PAX1
T6	disease 486 506	epithelial neoplasms
T7	gene 559 564	Sesn2
T8	disease 615 620	tumor
T9	disease 641 649	melanoma
T10	gene 754 759	Sesn2
T11	disease 763 782	metastatic melanoma
T12	gene 828 833	BCL-2
T13	disease 897 949	central nervous system diffuse large B-cell lymphoma
T14	disease 934 949	B-cell lymphoma
T15	gene 951 956	PD-L1
T16	disease 976 981	tumor
T17	gene 1072 1075	Src
T18	disease 1124 1138	lung carcinoma
T19	disease 1189 1201	glioblastoma
T20	gene 1226 1236	hnRNP A2B1
T21	disease 1284 1302	cholangiocarcinoma
T22	gene 1373 1398	cyclin‑dependent kinase 1
T23	gene 1417 1425	cyclin B
T24	gene 1432 1440	cyclin E
T25	disease 1445 1454	carcinoma
T26	gene 1466 1517	cystic fibrosis transmembrane conductance regulator
T27	gene 1519 1523	CFTR
T28	disease 1577 1595	secretory diarrhea
T29	gene 1668 1676	stathmin
T30	disease 1789 1805	myeloid leukemia
T31	gene 1817 1821	PKM2
T32	disease 1864 1885	endometrial carcinoma
T33	disease 2028 2034	tumors
T34	gene 2140 2145	BRCA1
T35	gene 2146 2151	BRCA2
T36	disease 2160 2166	tumors
T37	disease 2277 2293	low-grade glioma
T38	disease 2298 2310	glioblastoma
T39	gene 2365 2370	COPB2
T40	gene 2477 2484	insulin
T41	disease 2523 2531	diabetes
T42	disease 2603 2614	amyloidosis
T43	gene 2632 2636	TRAP
T44	gene 2856 2860	TRAP
T45	disease 2877 2884	anxiety
T46	gene 2954 2961	insulin
T47	disease 3006 3013	obesity
T48	disease 3087 3091	PCOS
T49	disease 3093 3118	Polycystic ovary syndrome
T50	disease 3261 3268	obesity
T51	gene 3274 3281	insulin
T52	gene 3322 3326	GRK2
T53	disease 3378 3393	medulloblastoma
R3	has_association_with Arg1:T5 Arg2:T6	
R4	contributes_to Arg1:T7 Arg2:T9	
R5	contributes_to Arg1:T10 Arg2:T11	
R6	contributes_to Arg1:T12 Arg2:T13	
R8	contributes_to Arg1:T17 Arg2:T18	
R9	contributes_to Arg1:T20 Arg2:T19	
R10	contributes_to Arg1:T22 Arg2:T21	
T55	corrected_gene 1417 1426	cyclin B1
T56	corrected_gene 1432 1441	cyclin E1
T57	corrected_gene 1400 1406	p‑CDK1
T58	corrected_gene 1409 1415	p‑CDK2
R11	contributes_to Arg1:T57 Arg2:T21	
R12	contributes_to Arg1:T58 Arg2:T21	
R13	contributes_to Arg1:T55 Arg2:T21	
R14	contributes_to Arg1:T56 Arg2:T21	
R15	contributes_to Arg1:T26 Arg2:T28	
R16	contributes_to Arg1:T27 Arg2:T28	
T59	corrected_disease 1600 1615	cystic fibrosis
R17	contributes_to Arg1:T27 Arg2:T59	
R18	contributes_to Arg1:T26 Arg2:T59	
T60	corrected_gene 2009 2013	PARP
T61	corrected_gene 2094 2098	PARP
R21	contributes_to Arg1:T60 Arg2:T33	
R22	contributes_to Arg1:T40 Arg2:T41	
R23	contributes_to Arg1:T52 Arg2:T53	
T62	corrected_gene 1170 1179	HCMV· ie2
R24	contributes_to Arg1:T62 Arg2:T19	
T63	corrected_disease 2802 2809	anxiety
R19	contributes_to Arg1:T43 Arg2:T63	
T64	DONE 3478 3482	DONE
R1	contributes_to Arg1:T3 Arg2:T4	
T54	corrected_disease 1085 1114	acquired cisplatin resistance
R2	contributes_to Arg1:T17 Arg2:T54	
T65	missed_disease 449 464	HPV16 infection
T66	missed_disease 854 871	inferior survival
T67	missed_disease_or_phenotypic_feature 615 637	tumor sphere formation
R7	has_association_with Arg1:T5 Arg2:T65	
R25	has_association_with Arg1:T15 Arg2:T16	
R20	has_association_with Arg1:T31 Arg2:T32	
